Skip to main content
Michael Peters, MD, Pulmonology, San Francisco, CA, UCSF Medical Center

MichaelPetersMDMAS

Pulmonology • San Francisco, CA

Asthma & COPD, Critical Care Medicine

UCSF

Join to view full profile

Dr. Peters is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Peters' full profile

Already have an account?

Education & Training

  • University of California, San Francisco
    University of California, San FranciscoMS, Clinical Research, 2013 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 2007 - 2010
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 2007
  • Emory University
    Emory UniversityB.A., Economics, 1998 - 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2010 - 2024
  • CO State Medical License
    CO State Medical License 2007 - 2010

Awards, Honors, & Recognition

  • Parker B. Francis Fellow Parker B. Francis Foundation
  • American Thoracic Society Abstract Scholarship American Thoracic Society, 2014
  • Parker B. Francis Respiratory Research Award 2015
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Intelectin-1 is a prominent protein constituent of pathologic mucus associated with eosinophilic airway inflammation in asthma  
    Kerr SC, Carrington SD, Oscarson S, Gallagher ME, Solon M, Yuan S, Ahn JN, Dougherty RH, Finkbeiner WE, Peters MC, Fahy JV, Am J Respir Crit Care Med, 1/1/2014
  • Measures of gene expression in sputum cells can identify Th2-high and Th2-low subtypes of asthma  
    Peters MC, Mekonnen ZK, Yuan S, Bhakta NR, Woodruff PG, Fahy JV, J Allergy Clin Immunol, 1/1/2013
  • CD94/NKG2 expression does not inhibit cytotoxic function of lymphocytic choriomeningitis virus-specific CD8+ T cells  
    Miller JD, Peters MC, Oran AE, Beresford GW, Harrington L, Boss JM, Altman JD, Journal of Immunology, 1/1/2002

Abstracts/Posters

  • Obesity interacts with airway Th2 inflammation to worsen asthma severity
    Peters MC, Mekonnen ZK, Fahy JV, American Thoracic Society, San Diego, CA, 1/1/2014
  • A Comparison on Non-Invasive Biomarkers of Airway Type-2 Inflammation in Asthma
    Peters MC
  • "IL-6 High" Asthma, a New Asthma Endotype Characterized by Severe Disease and Neutrophilia
    Peters MC

Lectures

  • Stability of Longitudinal Biomarkers in Severe Asthma 
    Orlando, Florida AAAAI - 3/4/2018
  • Increased Plasma IL-6 Identifies a Novel Severe Asthma Sub-Type 
    1/1/2015
  • IL-6 high asthma, a new asthma endotype characterized by severe disease and neutrophilia 
    Aspen, CO - 1/1/2015
  • Join now to see all

Press Mentions

  • The Day After Covid-19
    The Day After Covid-19September 23rd, 2020
  • How to Understand COVID-19 Numbers
    How to Understand COVID-19 NumbersAugust 6th, 2020

Grant Support

  • K-23 Uncovering Biologic Mechanisms of Severe AsthmaNIH/NHLBI2017–2021
  • Role of Type-2 cytokines and IL-6 in severe asthmaParker B. Francis Foundation2015–2018
  • T-32 Multidisciplinary Training Program in Lung DiseaseNIH/NHLBI2012–2014
  • K-12 Training Program in Pulmonary OmicsNIH/NHLBIPresent

Professional Memberships

Hospital Affiliations

Dr. Michael Peters, Dr. Michael Peters, MD, Dr. M Peters